Gao et al. reported TP53INP2 (tumor protein p53-inducible nuclear protein 2) to be efficiently linked with ER-negative BC in all three studied populations, i.e., African, European, and Asian ancestry populations (Gao et al., 2017). Here, TP53INP2 is linked to breast cancer.